AstraZeneca launches call for entries to the 2023 global R&D Postdoctoral Challenge

AstraZeneca has announced the launch of the 2023 R&D Postdoctoral Challenge, an initiative designed to accelerate ideas to transform the treatment of some of the world’s most complex diseases.

The R&D Postdoctoral Challenge has been designed to drive R&D productivity, promote diversity of thought and stimulate research opportunities across the globe.

from Breaking World Pharma News https://ift.tt/gdGpHQy